The Front Room — a clinical regulatory commons
RSS
← Back to feed

Caldolor indication expanded

Sponsor
Cumberland Pharmaceuticals Inc. $CPIX
Drug
Caldolor · ibuprofen
More on Cumberland Pharmaceuticals Inc. Google News

FDA approved an expanded indication for Caldolor (ibuprofen) injection based on Cumberland Pharmaceuticals' application.

What this means

Caldolor is an injected form of ibuprofen that reduces pain and swelling by blocking inflammation-causing chemicals in the body. The FDA cleared Caldolor for use in treating a broader range of conditions beyond its original approval. This expansion gives doctors more flexibility to use the fast-acting injectable version for patients who can't take pills or need quick relief.

Read original at accessdata.fda.gov
Topic indication expansion